JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: JNJ-1661010 (JNJ 1661010; Takeda-25; JNJ1661010; Takeda25), a piperazinyl phenyl urea compound, is a selective and reversible inhibitor of Fatty acid amide hydrolase/FAAH with important biological activity. It inhibits FAAH with an IC50 of 10 nM (rat) and 12 nM (human), and exhibits > 100-fold selectivity for FAAH-1 over FAAH-2. JNJ-1661010 is structurally distinct from alkylcarbamic acid esters and alpha–ketoheterocyclic compounds. JNJ-1661010 is a brain penetrant and active in vivo, and thus has been used to examine the contribution of endocannabinoid signaling in experimental fibrosis.
References: Bioorg Med Chem Lett. 2008 Sep 1; 18(17):4838-43; Anesth Analg. 2009 Jan; 108(1):316-29.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!